ElectronRx Launches pDx App for Remote COPD Management
“`html
electronRx’s pDx Platform Enables Remote Lung Function Monitoring
Table of Contents
A new remote patient monitoring platform,pDx,developed by electronRx,utilizes a device’s camera to track lung function and personalize respiratory care.The technology aims to improve drug efficacy, reduce healthcare burdens, and empower patients.
What is pDx and How Does it Work?
electronRx’s pDx platform is a non-invasive remote patient monitoring solution designed for individuals with breathing disorders. It leverages the camera sensors found in everyday devices – laptops,tablets,or smartphones – to capture and analyse blood flow biomechanics. This analysis generates digital biomarkers that translate into clinically relevant metrics, including heart rate, respiratory rate, and tidal volume. The system delivers this data in real-time to healthcare providers through a secure clinical dashboard.
Unlike conventional pulmonary function tests requiring clinic visits,pDx enables continuous,remote monitoring of lung function. This allows clinicians to dynamically adjust treatment plans to optimize efficacy of medications and interventions.
Benefits of Remote Lung Function Monitoring
The pDx platform offers several potential benefits for both patients and healthcare providers:
- Personalized Care: Continuous monitoring allows clinicians to tailor treatment plans to individual patient needs.
- Reduced Healthcare Burden: The platform’s scalable architecture supports integration into existing care pathways, potentially reducing the need for frequent in-person visits.
- Improved Patient Adherence: Greater flexibility and control over their healthcare journey can lead to better patient engagement and adherence to treatment plans.
- Proactive Intervention: Real-time data enables clinicians to identify potential issues early and intervene proactively.
electronRx’s Vision for the Future of Respiratory Care
electronRx is dedicated to transforming the lives of people living with breathing disorders. pDx represents a major step forward in personalised respiratory care and we very much look forward to demonstrating the technology at HLTH. The platform’s scalable architecture supports integration into existing care pathways, allowing for proactive intervention and reduced reliance on in-person visits. By facilitating continuous monitoring, pDx helps clinicians personalise care while improving patient adherence and reducing healthcare burden. Most importantly, it gives patients greater flexibility and control over their healthcare journey.”
Dr bipin Patel, CEO and founder, electronRx
Dr. Patel highlights the company’s commitment to improving the lives of those with breathing disorders and positions pDx as a key component of a more patient-centric approach to respiratory care. The platform is slated to be demonstrated at the HLTH conference, indicating a push for wider adoption and industry recognition.
The Growing Need for Remote Respiratory Monitoring
Chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), affect millions worldwide. According to the
